- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01891617
Exercise Effects on Insulin, Gut Peptides, and Appetite (XFG)
The Exercise Effects on Appetite and Gut Peptides While on High-fat Diet
Study Overview
Status
Intervention / Treatment
Detailed Description
Specific aim: Determine whether a change in macronutrient composition from 60% carbohydrate and 25% fat to 30% carbohydrate and 45% fat is responsible by itself for suppression of hunger and increased secretory response of glucose-dependent insulinotropic hormone (GIP) and glucagon-like peptide-1 (GLP-1), or whether these changes depend on preceding exercise. We will measure (a) concentrations of plasma GIP and GLP-1 by chemiluminescent multiplex assay, (b) concentrations of plasma ancetaminophen to assess the gastric emptying rate, (c) concentrations of plasma insulin, and glucagon by radioimmunoassay, and glucose, ketone bodies, and free fatty acids with appropriate spectrophotometric methods, (d) hourly appetite responses with visual analog scale under two conditions: sedentary (SED) and exercise (EX).
Hypothesis: Hunger suppression and secretion of GIP and GLP-1 after the morning meal will be greater with slower gastric emptying rate when a meal consisting of 45% fat and 30% carbohydrate follows three hours after a 2-hour bout of moderate-intensity exercise than in the absence of exercise.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- Michigan Clinical Research Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Postmenopausal status
- Age 50 to 65 years
- BMI between 20 and 30 kg/m2.
- Good health status (normotensive, fasting glucose < 100 mg/dl, , hematocrit > 32%, hemoglobin >12 mg/dl)
- Absence of restricted food intake
- Absence of endocrine and metabolic disorders requiring medication other than hormonally corrected hypothyroidism
- Absence of musculoskeletal disabilities that would prevent walking
Exclusion Criteria:
- Presence of endocrine and metabolic disease requiring medication, other than hormonally corrected hypothyroidism
- Presence of musculoskeletal disabilities that would prevent walking
- Smoking
- Active dieting
- Absence of listed inclusion criteria
- Unwillingness to follow study protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise-high-fat diet
Two bouts of exercise followed by a high-fat meal
|
Exercise and high-fat diet Exercise and high-carbohydrate diet Sedentary and high-fat diet Sedentary and high-carbohydrate diet
|
|
Experimental: Exercise-high-carbohydrate diet
Two bouts of exercise followed by a high-carbohydrate meal
|
Exercise and high-fat diet Exercise and high-carbohydrate diet Sedentary and high-fat diet Sedentary and high-carbohydrate diet
|
|
Experimental: Sedentary-high-fat diet
Sedentary trial with two high-fat meals
|
Exercise and high-fat diet Exercise and high-carbohydrate diet Sedentary and high-fat diet Sedentary and high-carbohydrate diet
|
|
Experimental: Sedentary-high-carbohydrate diet
Sedentary trial with two high-carbohydrate meals
|
Exercise and high-fat diet Exercise and high-carbohydrate diet Sedentary and high-fat diet Sedentary and high-carbohydrate diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma insulin concentration
Time Frame: 36 hours
|
Change in plasma insulin to two bouts of exercise followed by a high-carbohydrate or a high fat diet
|
36 hours
|
|
Plasma glucagon concentration
Time Frame: 36 hours
|
Changes in plasma glucagon concentration to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal
|
36 hours
|
|
Plasma concentration of glucose-dependent insulinotropic peptide (GIP)
Time Frame: 36 hours
|
Changes in plasma concentration of glucose-dependent insulinotropic peptide (GIP)to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal
|
36 hours
|
|
Plasma concentration of free fatty acids
Time Frame: 36 hours
|
Changes in plasma concentration of free fatty acidsto two bouts of exercise followed by either a high-carbohydrate or a high-fat meal
|
36 hours
|
|
Plasma concentration of beta-hydroxybutyrate
Time Frame: 36 hours
|
Changes in plasma concentration of beta-hydroxybutyrate to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal
|
36 hours
|
|
Plasma glucose concentration
Time Frame: 36 hours
|
Changes in plasma glucose concentration to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal
|
36 hours
|
|
daytime hourly appetite ratings
Time Frame: 36 hours
|
Changes in daytime hourly appetite ratings to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal
|
36 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma concentrations of glucagon-like peptide-1 (GLP-1)
Time Frame: 36 hours
|
Changes in plasma concentrations of glucagon-like peptide-1 (GLP-1)to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal
|
36 hours
|
|
Plasma concentrations of peptide tyrosine tyrosine (PYY)
Time Frame: 36 hours
|
Changes in plasma concentrations of peptide tyrosine tyrosine (PYY) to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal
|
36 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Katarina Borer, PhD, University of Michigan
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- R15DK082800-XFG
- R15DK082800 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endocrine and Metabolic Responses to Exercise and Diets
-
University of HoustonCompletedPhysiological and Psychological Responses to ExerciseUnited States
-
University of MichiganCompletedCellular Responses Within Skeletal Muscle in Response to Exercise of Different Intensities | Relationship Between the Cellular Responses in Skeletal Muscle and the Changes in the Metabolomic Profile | Changes Within Adipose Tissue in Response to Exercise at the Three Different IntensitiesUnited States
-
Texas State UniversityWithdrawnCardiovascular and Immune Responses to YogaUnited States
-
Institut Nacional d'Educacio Fisica de CatalunyaCompletedFibromyalgia | Hormonal Responses to Exercise in Patients With Fibromyalgia.Spain
-
Universidad Católica del UruguayNot yet recruitingGlycemic ResponsesUruguay
-
University of ManitobaRecruitingPhysiologic Responses to Surprise EventsCanada
-
University of VermontUnknownPhysiological Response to Exercise | Perception of Exercise DifficultyUnited States
-
University of BrasiliaConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedResistance Exercise Pressor and Neural Responses in Older Women
-
University of ThessalyCompletedEnergy Expenditure | Physiological Responses | Strength Training | Overweight and Obese Women | Pilates ExerciseGreece
-
Yale-NUS CollegeCompletedFocus of Study is Patient Responses to an Obesity Management Questionnaire Administered by SGH Life CentreSingapore
Clinical Trials on Exercise and diets
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedOverweight | Obese | Sedentary | Abdominal ObesityUnited States
-
Chonbuk National University HospitalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Osaka UniversityActive, not recruitingChronic Kidney Disease Stage 5Japan
-
Medical University of BialystokCompletedObesity | Hashimoto DiseasePoland
-
Sheba Medical CenterTel Aviv UniversityUnknown
-
University of MinnesotaCompleted
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | ObesityUnited States
-
Iuliu Hatieganu University of Medicine and PharmacyCompletedWeight Loss | Glucose, High Blood | LDL Hyperlipoproteinemia | HDL | Triglycerides High
-
University Hospital Inselspital, BerneCompletedRenal Failure | Renal Transplantation | Living DonorsSwitzerland
-
Rigshospitalet, DenmarkCompleted